Tvardi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TVRD and other ETFs, options, and stocks.About TVRD
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
TVRD Key Statistics
Stock Snapshot
With a market cap of 33.02M, Tvardi Therapeutics(TVRD) trades at $3.54. The stock has a price-to-earnings ratio of -0.63.
On 2026-05-05, Tvardi Therapeutics(TVRD) stock traded between a low of $3.14 and a high of $3.68. Shares are currently priced at $3.54, which is +12.7% above the low and -3.8% below the high.
The Tvardi Therapeutics(TVRD)'s current trading volume is 82.29K, compared to an average daily volume of 29.74K.
In the last year, Tvardi Therapeutics(TVRD) shares hit a 52-week high of $43.65 and a 52-week low of $2.75.
In the last year, Tvardi Therapeutics(TVRD) shares hit a 52-week high of $43.65 and a 52-week low of $2.75.
Analyst ratings
50%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.